SCHEMBL22656552

SCHEMBL22656552

CC(C)(C)OC(=O)COc1ccccc1OCC(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GLA P06280 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HPGD P15428 2/20 0.49
MAPT P10636 2/20 0.49
DDB1 Q16531 1/20 0.49
CRBN Q96SW2 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ALDH1A1 P00352 3/20 0.45
HTT P42858 1/20 0.45
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 2/20 0.44
PTPN1 P18031 1/20 0.44
MEN1 O00255 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19423149 0.93 SMN1; SMN2 (0.62) POLBSMN1; SMN2HPGDMAPTNPSR1
SCHEMBL22396691 0.90 POLB (0.46) POLBSMN1; SMN2GLAL3MBTL1HPGD
SCHEMBL7862085 0.90 NOTUM (0.53) SMN1; SMN2MAPTDDB1CRBNCYP2C9
SCHEMBL10257400 0.88 NPSR1 (0.55) POLBHPGDMAPTDDB1CRBN
SCHEMBL14277707 0.88 GRM4 (0.51) POLBSMN1; SMN2L3MBTL1HPGDMAPT
SCHEMBL9644169 0.88 MAPT (0.53) POLBSMN1; SMN2GLAL3MBTL1HPGD
SCHEMBL8372903 0.88 NPSR1 (0.45) POLBSMN1; SMN2GLAL3MBTL1HPGD
SCHEMBL12145899 0.88 POLB (0.44) POLBSMN1; SMN2GLAL3MBTL1HPGD
SCHEMBL30301257 0.88 NPSR1 (0.55) POLBHPGDMAPTDDB1CRBN
SCHEMBL2635721 0.88 ALDH1A1 (0.49) POLBSMN1; SMN2GLAL3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704094-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-11 EP disclosed
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-05-23 US disclosed
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 POLB 1764/4885SMN1; SMN2 2486/4885GLA 3741/4885
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 POLB 1764/4885SMN1; SMN2 2486/4885GLA 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.